The Cigna Group posted strong Q3 2024 results, yet CI stock is down nearly 20% from its 52-week high. See why this may ...

Cigna reported better-than-expected earnings Thursday and maintained its full-year guidance, lifting the shares.

The company sees strong interest in tailored provider networks that cater to employee needs, as well as obesity drug cost ...

Ballad Health and Cigna are working to finalize negotiations as a New Year’s Eve deadline looms to keep some of the insurance ...

The Cigna Group on Thursday reported a nearly $740 million profit for the third quarter of 2024, despite an after-tax loss of ...

Cigna surpassed quarterly profit estimates on Thursday, driven by strong demand for its specialty drugs and new clients for ...

Cigna (CI) stock gained as company beats Q3 forecasts , driven by Evernorth unit's performance: adjusted income up 5% YoY to $2.1B, revenue at $63.7B. Read more here.

Ballad Health facilities and providers could soon be considered "out-of-network" for those carrying Cigna Healthcare insurance. Negotiations between Ballad and Cigna for the insurance to remain ...

TD Cowen analyst Ryan Langston has maintained their bullish stance on CI stock, giving a Buy rating today. Ryan Langston’s rating is ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Voyager Therapeutics (VYGR – Research Report), Align Tech ...

Cigna reports Q3 sales of $63.7 billion, a 30% YoY increase, driven by Evernorth growth. Adjusted EPS of $7.51 beats estimates. 2024 EPS guidance reaffirmed.

Health insurance company Cigna Group (CI) topped revenue and profit estimates in its third quarter earnings results, while the company reaffirmed its full-year outlook Morning Brief anchors Julie ...